16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      AAPM Task Group 198 Report: An implementation guide for TG 142 quality assurance of medical accelerators

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          Task Group 142 report: quality assurance of medical accelerators.

          The task group (TG) for quality assurance of medical accelerators was constituted by the American Association of Physicists in Medicine's Science Council under the direction of the Radiation Therapy Committee and the Quality Assurance and Outcome Improvement Subcommittee. The task group (TG-142) had two main charges. First to update, as needed, recommendations of Table II of the AAPM TG-40 report on quality assurance and second, to add recommendations for asymmetric jaws, multileaf collimation (MLC), and dynamic/virtual wedges. The TG accomplished the update to TG-40, specifying new test and tolerances, and has added recommendations for not only the new ancillary delivery technologies but also for imaging devices that are part of the linear accelerator. The imaging devices include x-ray imaging, photon portal imaging, and cone-beam CT. The TG report was designed to account for the types of treatments delivered with the particular machine. For example, machines that are used for radiosurgery treatments or intensity-modulated radiotherapy (IMRT) require different tests and/or tolerances. There are specific recommendations for MLC quality assurance for machines performing IMRT. The report also gives recommendations as to action levels for the physicists to implement particular actions, whether they are inspection, scheduled action, or immediate and corrective action. The report is geared to be flexible for the physicist to customize the QA program depending on clinical utility. There are specific tables according to daily, monthly, and annual reviews, along with unique tables for wedge systems, MLC, and imaging checks. The report also gives specific recommendations regarding setup of a QA program by the physicist in regards to building a QA team, establishing procedures, training of personnel, documentation, and end-to-end system checks. The tabulated items of this report have been considerably expanded as compared with the original TG-40 report and the recommended tolerances accommodate differences in the intended use of the machine functionality (non-IMRT, IMRT, and stereotactic delivery).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The management of respiratory motion in radiation oncology report of AAPM Task Group 76.

            This document is the report of a task group of the AAPM and has been prepared primarily to advise medical physicists involved in the external-beam radiation therapy of patients with thoracic, abdominal, and pelvic tumors affected by respiratory motion. This report describes the magnitude of respiratory motion, discusses radiotherapy specific problems caused by respiratory motion, explains techniques that explicitly manage respiratory motion during radiotherapy and gives recommendations in the application of these techniques for patient care, including quality assurance (QA) guidelines for these devices and their use with conformal and intensity modulated radiotherapy. The technologies covered by this report are motion-encompassing methods, respiratory gated techniques, breath-hold techniques, forced shallow-breathing methods, and respiration-synchronized techniques. The main outcome of this report is a clinical process guide for managing respiratory motion. Included in this guide is the recommendation that tumor motion should be measured (when possible) for each patient for whom respiratory motion is a concern. If target motion is greater than 5 mm, a method of respiratory motion management is available, and if the patient can tolerate the procedure, respiratory motion management technology is appropriate. Respiratory motion management is also appropriate when the procedure will increase normal tissue sparing. Respiratory motion management involves further resources, education and the development of and adherence to QA procedures.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40.

                Bookmark

                Author and article information

                Journal
                Medical Physics
                Medical Physics
                Wiley
                0094-2405
                2473-4209
                October 2021
                August 11 2021
                October 2021
                : 48
                : 10
                Affiliations
                [1 ]Princeton Radiation Oncology Monroe New Jersey08831USA
                [2 ]Winship Cancer Institute, Radiation Oncology Emory University Atlanta Georgia30322USA
                [3 ]Sun Nuclear Corp Melbourne Florida32940USA
                [4 ]Department of Radiation Oncology University of Iowa Iowa City, Iowa52242USA
                [5 ]Brown university Rhode Island Hospital Providence Rhode Island02905USA
                [6 ]Princess Margaret Cancer Centre TorontoM5G 2M9Canada
                [7 ]University of Florida Gainesville Florida32610‐0385USA
                [8 ]Department of Radiation Oncology Duke University Medical Center Durham North Carolina27710USA
                [9 ]Karmanos Cancer Institute at McLaren‐Flint Flint Michigan48532USA
                [10 ]Department of Radiation Oncology University of California San Francisco San Francisco94143‐0226USA
                [11 ]MD Anderson Cancer Center Mansfield OH44907USA
                [12 ]Department of Radiation Oncology The University of Colorado Health—Poudre Valley Fort Collins Colorado80525USA
                [13 ]Department of Human Oncology School of Medicine and Public Health University of Wisconsin—Madison Madison Wisconsin53792‐0600USA
                [14 ]Varian Medical Systems Palo Alto California94304USA
                Article
                10.1002/mp.14992
                34036590
                a7e38fb0-4dfe-4bc7-9220-fd5557677090
                © 2021

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article